Your browser doesn't support javascript.
loading
Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes.
Yamazaki, Daiju; Kitaguchi, Takashi; Ishimura, Masakazu; Taniguchi, Tomohiko; Yamanishi, Atsuhiro; Saji, Daisuke; Takahashi, Etsushi; Oguchi, Masao; Moriyama, Yuta; Maeda, Sanae; Miyamoto, Kaori; Morimura, Kaoru; Ohnaka, Hiroki; Tashibu, Hiroyuki; Sekino, Yuko; Miyamoto, Norimasa; Kanda, Yasunari.
Afiliación
  • Yamazaki D; Japan iPS Cardiac Safety Assessment (JiCSA), Japan; Division of Pharmacology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
  • Kitaguchi T; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Mochida Pharmaceutical Co. Ltd., 722 Uenohara, Jimba, Gotemba, Shizuoka 412-8524, Japan.
  • Ishimura M; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Kaken Pharmaceutical Co. Ltd., 14 Minamikawahara-cho, Shinomiya, Yamashina-ku, Kyoto, 607-8042, Japan.
  • Taniguchi T; Japan iPS Cardiac Safety Assessment (JiCSA), Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Eisai Co. Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Yamanishi A; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Kyorin Pharmaceutical Co. Ltd., 1848 Nogi, Nogimachi, Shimotsugagun, Tochigi 329-0114, Japan.
  • Saji D; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; NISSEI BILIS Co. Ltd., 555 Ukawa, Minakuchi-cho, Koka, Shiga 528-0052, Japan.
  • Takahashi E; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Toyama Chemical Co. Ltd., 2-4-1 Shimookui, Toyama, Toyama 930-8508, Japan.
  • Oguchi M; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Ina Research Inc., 2148-188 Nishiminowa, Ina-shi, Nagano 399-4501, Japan.
  • Moriyama Y; Mochida Pharmaceutical Co. Ltd., 722 Uenohara, Jimba, Gotemba, Shizuoka 412-8524, Japan.
  • Maeda S; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Eisai Co. Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Miyamoto K; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Toyama Chemical Co. Ltd., 2-4-1 Shimookui, Toyama, Toyama 930-8508, Japan.
  • Morimura K; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Toyama Chemical Co. Ltd., 2-4-1 Shimookui, Toyama, Toyama 930-8508, Japan.
  • Ohnaka H; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; NISSEI BILIS Co. Ltd., 555 Ukawa, Minakuchi-cho, Koka, Shiga 528-0052, Japan.
  • Tashibu H; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Ina Research Inc., 2148-188 Nishiminowa, Ina-shi, Nagano 399-4501, Japan.
  • Sekino Y; Japan iPS Cardiac Safety Assessment (JiCSA), Japan; Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Miyamoto N; Japan iPS Cardiac Safety Assessment (JiCSA), Japan; Consortium for Safety Assessment Using Human iPS Cells (CSAHi), Japan; Eisai Co. Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
  • Kanda Y; Japan iPS Cardiac Safety Assessment (JiCSA), Japan; Division of Pharmacology, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan. Electronic address: kanda@nihs.go.jp.
J Pharmacol Sci ; 136(4): 249-256, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29555184
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arritmias Cardíacas / Miocitos Cardíacos / Descubrimiento de Drogas / Células Madre Pluripotentes Inducidas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arritmias Cardíacas / Miocitos Cardíacos / Descubrimiento de Drogas / Células Madre Pluripotentes Inducidas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Pharmacol Sci Asunto de la revista: FARMACOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Japón